U.S. Brachytherapy Market Size & Outlook, 2020-2028
U.S. brachytherapy market, 2017-2028 (US$M)
Related Markets
U.S. brachytherapy market highlights
- The U.S. brachytherapy market generated a revenue of USD 327.3 million in 2020 and is expected to reach USD 544.0 million by 2028.
- The U.S. market is expected to grow at a CAGR of 6.6% from 2021 to 2028.
- In terms of segment, high-dose rate (hdr) brachytherapy was the largest revenue generating dosage type in 2020.
- High-Dose Rate (HDR) Brachytherapy is the most lucrative dosage type segment registering the fastest growth during the forecast period.
Brachytherapy market data book summary
| Market revenue in 2020 | USD 327.3 million |
| Market revenue in 2028 | USD 544.0 million |
| Growth rate | 6.6% (CAGR from 2020 to 2028) |
| Largest segment | High-dose rate (hdr) brachytherapy |
| Fastest growing segment | High-Dose Rate (HDR) Brachytherapy |
| Historical data | 2017 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | High-Dose Rate (HDR) Brachytherapy, Low-Dose Rate (LDR) Brachytherapy |
| Key market players worldwide | Siemens Healthineers AG ADR, Becton Dickinson & Co, Elekta AB ADR, Icad Inc, Roper Technologies Inc, Ustar, IsoRay, Eckert & Ziegler Bebig SA |
Other key industry trends
- In terms of revenue, U.S. accounted for 41.5% of the global brachytherapy market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In North America, U.S. brachytherapy market is projected to lead the regional market in terms of revenue in 2028.
- Canada is the fastest growing regional market in North America and is projected to reach USD 55.5 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Brachytherapy Market Scope
Brachytherapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. brachytherapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to brachytherapy market will help companies and investors design strategic landscapes.
High-dose rate (hdr) brachytherapy was the largest segment with a revenue share of 71.4% in 2020. Horizon Databook has segmented the U.S. brachytherapy market based on high-dose rate (hdr) brachytherapy, low-dose rate (ldr) brachytherapy covering the revenue growth of each sub-segment from 2017 to 2028.
U.S brachytherapy market is expected to grow with a CAGR of 3.9%. Introduction of new and innovative technologies is expected to fuel the market growth.
For instance, In June 2018, IsoRay, Inc. launched its new Build-Blu delivery system for prostate brachytherapy. It is the first disposable and affordable delivery system for personalized Cesium-131 treatment.
Reasons to subscribe to U.S. brachytherapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. brachytherapy market databook
-
Our clientele includes a mix of brachytherapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. brachytherapy market , including forecasts for subscribers. This country databook contains high-level insights into U.S. brachytherapy market from 2017 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. brachytherapy market size, by dosage type, 2017-2028 (US$M)
U.S. Brachytherapy Market Outlook Share, 2020 & 2028 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
